Jolly S R, Smith R D, Wolf P S, Russ T P
Res Commun Chem Pathol Pharmacol. 1986 Dec;54(3):339-54.
The role of alpha-adrenergic systems in modulating contractility and rate in the canine heart is not completely understood. This was evaluated by examining alpha-agonists and antagonists in ganglionic- and beta-blocked, anesthetized dogs. Also, partial agonist effects of the beta-blocker celiprolol in the ganglionic blocked dog are insensitive to propranolol and may be mediated via alpha-2 antagonism. Prazosin (0.3 mg/kg), yohimbine (0.3 mg/kg), celiprolol (3 mg/kg) and vehicle were administered to ganglionic-(mecamylamine 2 mg/kg) and beta-adrenergic-(propranolol 1 mg/kg + 0.3 mg/kg/hr) blocked dogs. Clonidine (0.3 and 3.0 micrograms/kg), phenylephrine (3 micrograms/kg) and norepinephrine (0.3 microgram/kg) produced significant increases in arterial pressure with minimal chronotropic or inotropic effects. Celiprolol produced sustained increases in heart rate and contractile force of 15 +/- 3 beats/min and 33 +/- 7 percent (X +/- SEM) without significant vascular alpha antagonism. Yohimbine, prazosin and vehicle were without significant chronotropic or inotropic effects. However, yohimbine and prazosin selectively reduced pressor responses to clonidine and phenylephrine, respectively. In further studies adding prazosin or phentolamine before treatment with celiprolol did not attenuate its effects on heart rate and contractility. These results do not support significant inotropic or chronotropic effects of alpha-adrenergic receptor modulation in anesthetized dogs. The cardiac stimulatory effects of celiprolol do not appear to be mediated via cardiac alpha receptors.
α-肾上腺素能系统在调节犬心脏收缩力和心率方面的作用尚未完全明确。通过对神经节阻断且β受体阻断的麻醉犬使用α激动剂和拮抗剂进行了评估。此外,β受体阻滞剂塞利洛尔在神经节阻断犬中的部分激动剂作用对普萘洛尔不敏感,可能通过α₂拮抗作用介导。将哌唑嗪(0.3mg/kg)、育亨宾(0.3mg/kg)、塞利洛尔(3mg/kg)和赋形剂给予神经节阻断(美加明2mg/kg)和β肾上腺素能阻断(普萘洛尔1mg/kg + 0.3mg/kg/小时)的犬。可乐定(0.3和3.0μg/kg)、去氧肾上腺素(3μg/kg)和去甲肾上腺素(0.3μg/kg)使动脉压显著升高,同时心率或心肌收缩力影响最小。塞利洛尔使心率和收缩力持续增加,分别为15±3次/分钟和33±7%(X±SEM),且无明显的血管α拮抗作用。育亨宾、哌唑嗪和赋形剂对心率和心肌收缩力无明显影响。然而,育亨宾和哌唑嗪分别选择性降低了对可乐定和去氧肾上腺素的升压反应。在进一步的研究中,在使用塞利洛尔治疗前添加哌唑嗪或酚妥拉明并未减弱其对心率和收缩力的影响。这些结果不支持α-肾上腺素能受体调节在麻醉犬中具有显著的心肌收缩力或心率影响。塞利洛尔的心脏刺激作用似乎不是通过心脏α受体介导的。